For those with Treatment-Resistant Depression (TRD), life can be overwhelming, even bringing on suicidal thoughts or actions. The GRAND Infusion Center can help, offering the latest, FDA-approved treatment for Treatment-Resistant Major Depressive Disorder (MDD).
I’ve been severely depressed since childhood and have had thoughts of suicide many times. My outpatient therapist suggested GRAND Infusion, and after just 7 treatments, I’m feeling so much better.
-Tosha N
Utilizing FDA-approved SpravatoÒ (esketamine), GRAND Infusion Center clients self-administer treatments through a simple intra-nasal spray under the supervision of a licensed health care provider in our certified clinic.
Clients remain under observation for approximately two hours in the clinic. This observation time is crucial as the immediate side effects can include a distortion of an individual’s perception. Within these two hours, the disorientation significantly decreases and patients often describe increased calm and less distress from their depression.
For some patients, there is a significant and immediate decrease in depressive symptoms.
The GRAND Infusion Center treatment team, under the leadership of Psychiatrist Kahlil Michael Saliba, M.D., has more than 25 years of experience in the medical field, with specialized experience in Treatment Resistant Major Depressive Disorder, including Ketamine treatment. The team played a vital role in the state of Oklahoma’s Spravato launch.
REQUEST AN APPOINTMENT MAKE A REFERRAL